Aicuris reports positive Phase III pritelivir results for HSV patients
Aicuris has reported positive findings from its pivotal Phase III trial (PRIOH-I) assessing pritelivir in immunocompromised patients with refractory herpes…
All articles by Salong Debbarma
Salong Debbarma
-
-
TransCode and Quantum Leap seek FDA approval for Phase IIa TTX-MC138 trial
A partnership comprising TransCode Therapeutics and Quantum Leap Healthcare Collaborative has submitted an investigational new drug (IND) application amendment seeking…
-
DiMe unveils sDHT Adoption Navigator to advance clinical trial integration
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) has introduced the sDHT Adoption Navigator, an…
-
Affinia receives FDA approval for Phase I/II trial for dilated cardiomyopathy
Affinia Therapeutics has received approval from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application…
-
Invivyd aligns with FDA advice on LIBERTY Phase III Covid-19 trial
Invivyd has received advice from the US Food and Drug Administration (FDA) and is aligned with it on the LIBERTY Phase III…
-
Biosion doses first patient in Phase Ia/Ib BSI-082 trial for solid tumours
Biosion has dosed the first patient in an investigator-initiated Phase Ia/Ib trial of BSI-082, a fully human anti-SIRPα monoclonal antibody,…
-
SEQSTER and Praxis expand collaboration to expedite CNS disorder trials
SEQSTER has announced the expansion of its partnership with Praxis Precision Medicines to expedite clinical trials in central nervous system…
-
Arcutis reports positive topline data in Zoryve trial for infant AD
Arcutis has reported positive topline data from the INTEGUMENT-INFANT Phase II trialassessing Zoryve (roflumilast) cream 0.05% in infants aged three…
-
Jumo Health introduces clinical trial recruitment system
Jumo Health has launched PRISM, a clinical trial recruitment, enrolment, and retention system targeting persistent failures in research. The system…
-
ALX Oncology announces Phase Ib/II trial results for breast cancer
ALX Oncology has announced new data from a Phase Ib/II clinical trial of its cluster of differentiation 47 (CD47)-inhibitor, evorpacept,…